The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Open accessAbstract
Manipulation of the Hippo signaling pathway with a reversible and selective small-molecule inhibitor of Hippo kinase MST1/2 provides a therapeutic option for tissue injury and repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Wound repair and regeneration: Mechanisms, signaling, and translation
Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 1×
“Previous studies have shown that cell-cell contact and high cell density activate Hippo signaling to inhibit YAP activity by promoting cytoplasmic retention (21).”
BackgroundA quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
Clinicopathologic study of dextran sulfate sodium experimental acute colitis
Shichijo, K., Matuu, M., Ikeda, Y., Naito, S., Ito, M., & Sekine, I. (1998) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)41298-5 · Cited by 1,943
The Hippo pathway and human cancer
Harvey, K. F., Zhang, X., & Thomas, D. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3458 · Cited by 1,842
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
Cited by
Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine
Moya, I. M., & Halder, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0086-y · Cited by 981
The Hippo Signaling Pathway in Development and Disease
Zheng, Y., & Pan, D. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.06.003 · Cited by 867
“Indeed, a small molecule inhibitor of MST1/2 (XMU-MP-1) has been shown to facilitate intestinal and hepatic repair upon injury (Fan et al., 2016).”
BackgroundTargeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0070-z · Cited by 860
The Hippo signalling pathway and its implications in human health and diseases
Fu, M., Hu, Y., Lan, T., Guan, K.-L., Luo, T., & Luo, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01191-9 · Cited by 742
Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk
Wang, L., You, X., Lotinun, S., Zhang, L., Wu, N., & Zou, W. (2020) · Nature Communications · doi:10.1038/s41467-019-14146-6 · Cited by 526
Tissue geometry drives deterministic organoid patterning
Gjorevski, N., Nikolaev, M., Brown, T. E., Mitrofanova, O., Brandenberg, N., DelRio, F. W., Yavitt, F. M., Liberali, P., Anseth, K. S., & Lutolf, M. P. (2022) · Science · doi:10.1126/science.aaw9021 · Cited by 505
Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Calses, P. C., Crawford, J. J., Lill, J. R., & Dey, A. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.04.001 · Cited by 420
Zhou, T., Gao, B., Fan, Y., Liu, Y., Feng, S., Cong, Q., Zhang, X., Zhou, Y., Yadav, P. S., Lin, J., et al. (2020) · eLife · doi:10.7554/elife.52779 · Cited by 392
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, R., & Hansen, C. G. (2022) · Clinical Science · doi:10.1042/cs20201474 · Cited by 326
Mills, R. J., Parker, B. L., Quaife-Ryan, G. A., Voges, H. K., Needham, E. J., Bornot, A., Ding, M., Andersson, H., Polla, M., Elliott, D. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.009 · Cited by 312
Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration
Lu, L., Finegold, M. J., & Johnson, R. L. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.205 · Cited by 190
Understanding Liver Regeneration
Gilgenkrantz, H., & Collin de l'Hortet, A. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.03.008 · Cited by 171
Zheng, Y., Liu, B., Wang, L., Lei, H., Pulgar Prieto, K. D., & Pan, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.076 · Cited by 110
“Drug treatment The MST1/2 inhibitor XMU-MP-1HAP1 (Y-100526) was purchased from Medchemexpress.”
BackgroundInfluentialWang, H., Shang, Y., Wang, E., Xu, X., Zhang, Q., Qian, C., Yang, Z., Wu, S., & Zhang, T. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102280 · Cited by 107
Verboven, E., Moya, I. M., Sansores-Garcia, L., Xie, J., Hillen, H., Kowalczyk, W., Vella, G., Verhulst, S., Castaldo, S. A., Algueró-Nadal, A., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.10.035 · Cited by 87
Bou Saleh, M., Louvet, A., Ntandja-Wandji, L. C., Boleslawski, E., Gnemmi, V., Lassailly, G., Truant, S., Maggiotto, F., Ningarhari, M., Artru, F., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.041 · Cited by 83
The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
Nguyen‐Lefebvre, A. T., Selzner, N., Wrana, J. L., & Bhat, M. (2021) · The FASEB Journal · doi:10.1096/fj.202002284rr · Cited by 58
Gao, Y., Fan, S., Li, H., Jiang, Y., Yao, X., Zhu, S., Yang, X., Wang, R., Tian, J., Gonzalez, F. J., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.021 · Cited by 41
Zhang, S., Guo, M., Jiang, X., Tang, L., Wu, T., Bi, G., Yang, X., Fan, S., & Bi, H. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106666 · Cited by 37
Self-citationAlternative Cell Sources for Liver Parenchyma Repopulation: Where Do We Stand?
Tricot, T., De Boeck, J., & Verfaillie, C. (2020) · Cells · doi:10.3390/cells9030566 · Cited by 20
Stepan, J., Heinz, D. E., Dethloff, F., Wiechmann, S., Martinelli, S., Hafner, K., Ebert, T., Junglas, E., Häusl, A. S., Pöhlmann, M. L., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adj6603 · Cited by 20
“To interfere with LATS1/2 phosphorylation in vivo, we blocked the upstream kinases MST1 and MST2 (MST1/2) ( 30 ) with the small-molecule inhibitor XMU-MP1 (hereafter, MSTi) ( 31 – 33 ).”
Over‐expressed MST1 impaired spatial memory via disturbing neural oscillation patterns in mice
Shang, Y., Yan, Y., Chen, B., Zhang, J., & Zhang, T. (2020) · Genes, Brain and Behavior · doi:10.1111/gbb.12678 · Cited by 15
Metadata
- Authors
- Fan, F., He, Z., Kong, L.-L., Chen, Q., Yuan, Q., Zhang, S., Ye, J., Liu, H., Sun, X., Geng, J., Yuan, L., Hong, L., Xiao, C., Zhang, W., Sun, X., Li, Y., Wang, P., Huang, L., Wu, X., Ji, Z., Wu, Q., Xia, N.-S., Gray, N. S., Chen, L., Yun, C.-H., Deng, X., & Zhou, D.
- Venue
- Science Translational Medicine
- Published
- 2016-08-17
- Volume
- 8
- Issue
- 352
- Pages
- 352ra108-352ra108
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2512544075
- Cited by
- 382
- References
- 43
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.